AJP Legacy  AJP: Regulatory, Integrative and Comparative Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol 228: 448-453, 1975;
0002-9513/75 $5.00
This Article
Right arrow Full Text (PDF)
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miller ED,
Right arrow Articles by Barger, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller ED, , Jr
Right arrow Articles by Barger, A.
American Journal of Physiology, Vol 228, Issue 2, 448-453
Copyright © 1975 by American Physiological Society


ARTICLES

Inhibition of angiotensin conversion and prevention of renal hypertension

Miller ED Jr, AI Samuels, E Haber, and AC Barger

Renal artery constriction in the unilaterally nephrectomized, trained dog, with maintained renal arterial hypotension, produces a prompt increase in systemic renin activity and blood pressure. The hypertension normally induced by renal artery stenosis is prevented by prior treatment with the nonapeptide Pyr-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro (SQ 20, 881), which blocks conversion of angiotensin I to angiotensin II. Constant intravenous infusion of the inhibitor over several days of renal artery constriction prevents the development of chronic renovascular hypertension. Furthermore, a single injection of the nonapeptide restores blood pressure to normal in the early phase of renovascular hypertension, but becomes progressively less effective as salt and water retention occurs in the chronic stage when plasma renin activity returns to control levels. These data provide strong evidence that the renin-angiotensin system is responsible for the initiation of renovascular hypertension in the one-kidney Goldblatt dog, but that other factors become increasingly important in chronic renovascular hypertension.


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. F. Reckelhoff and J. C. Romero
Role of oxidative stress in angiotensin-induced hypertension
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2003; 284(4): R893 - R912.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. Amiri and R. Garcia
Renal Angiotensin II Receptor Regulation in Two-Kidney, One Clip Hypertensive Rats : Effect of ACE Inhibition
Hypertension, September 1, 1997; 30(3): 337 - 344.
[Abstract] [Full Text]


Home page
ANGIOLOGYHome page
T. Rosenthal, E. Kissin, E.T. Jacob, N. Stern, Y. Levi, and R. Adar
Angiotensin-Converting Enzyme Inhibitor (SQ 20881) in the Diagnosis of Renovascular Hypertension
Angiology, February 1, 1979; 30(2): 123 - 128.
[Abstract] [PDF]


Home page
ScienceHome page
P. Caldwell, B. Seegal, K. Hsu, M Das, and R. Soffer
Angiotensin-converting enzyme: vascular endothelial localization
Science, March 12, 1976; 191(4231): 1050 - 1051.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 1975 by the American Physiological Society.